Sign Up Today and Learn More About SonoThera Stock
Invest in or calculate the value of your shares in SonoThera or other pre-IPO companies through EquityZen's platform.
SonoThera Stock (SONO)
SonoThera is a biotechnology company that creates non-viral genetic therapies using ultrasound.
About SonoThera Stock
Founded
2021
Headquarters
San Francisco, CA, US
Industries
Content and Publishing, Messaging and Telecommunications, Sports
SonoThera Press Mentions
Stay in the know about the latest news on SonoThera
SonoThera™ to Present New Data at ASGCT 2025 Demonstrating the Potential of Genetic Medicine Using Targeted, Ultrasound-Mediated Delivery in Treating Duchenne Muscular Dystrophy and Hemophilia A
biospace • May 06, 2025
SonoThera™ to Present New Data at ASGCT 2025 Demonstrating the Potential of Genetic Medicine Using Targeted, Ultrasound-Mediated Delivery in Treating Duchenne Muscular Dystrophy and Hemophilia A
businesswire • May 06, 2025
Methods and systems for improved delivery via ultrasound
patents • Apr 02, 2025
Methods and systems for improved nucleic acid delivery via ultrasound
patents • Feb 08, 2025
Methods and systems for improved nucleic acid delivery via ultrasound
patents • Feb 08, 2025
SonoThera Management
Leadership team at SonoThera
Board Member
Steven Gillis
Board Member
Tom Willis
Join now and verify your accreditation status to gain access to:
- SonoThera Current Valuation
- SonoThera Stock Price
- SonoThera Management
- Available deals in SonoThera and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- SonoThera Cap Table and Funding History by Share Class and Liquidity Preferences
- SonoThera Revenue and Financials
- SonoThera Highlights
- SonoThera Business Model
- SonoThera Risk Factors
- SonoThera Research Report from SACRA Research
Trading SonoThera Stock
How to invest in SonoThera stock?
Accredited investors can buy pre-IPO stock in companies like SonoThera through EquityZen funds. These investments are made available by existing SonoThera shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell SonoThera stock?
Shareholders can sell their SonoThera stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
